Tag Archives: Alzheimer’s Research UK

More on the The Lancet Commission on Dementia Prevention, Intervention, and Care (Irish Journal of Psychological Medicine / Lancet)

Posted on September 29, 2019 by Dementia and Elderly Care News

Summary The Lancet Commission on Dementia Prevention, Intervention, and Care has produced recommendations for the prevention of dementia, proposing a “life-course model of dementia prevention” incorporating nine modifiable risk factors for reducing the risk of dementia. The commission also offers recommendations about the pharmacological, … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Management of Condition, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Ageing Population Carer Support, Alzheimer's Research UK, Australia, Barriers to Support, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Blood Pressure, Brighton and Sussex Medical School: University of Sussex, Cambridge Institute of Public Health: University of Cambridge, Camden and Islington NHS Foundation Trust, Canada, Center for Innovative Care in Aging: Johns Hopkins University, Centre for Clinical Brain Sciences: University of Edinburgh, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Dementia Studies: University of Manchester, Centre for Dementia Studies: University of Sussex, Centre for Old Age Psychiatric Research (Innlandet Hospital Trust), Centre for Research in Ageing and Cognitive Health: University of Exeter, Centre for the Health Care of Elderly People: Dalhousie University, Cognitive Decline and Dementia: Risk Reduction, Cumulative Benefit of Reducing Risk Factors, Dalhousie University (Halifax; Canada), Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia and Sensory Loss, Dementia Policy, Dementia Prevention, Dementia Research, Dementia Research Centre: University College London, Dementia Research Priorities, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Department of Health Promotion: Tel-Aviv University, Department of Medicine: University of Washington, Department of Neurology and Department of Psychiatry and the Behavioural Sciences: Keck School of Medicine, Department of Psychiatry and Behavioral Sciences: Johns Hopkins Bayview, Department of Psychiatry: University of Michigan, Department Psychosocial and Community Health: University of Washington, Diet and Dementia, Dietary Factors, Division of Psychiatry: University College London, Economic and Social Research Council (ESRC), Faculty of Medicine: University of Oslo, France, Geriatric Medicine: Dalhousie University, Healthy Ageing, Healthy and Active Ageing: Life-Course Approach (WHO), Healthy Lifestyles, Healthy Lifestyles and Public Health Programmes, Healthy Living, Heczeg Institute on Aging: Tel Aviv University, Increasing Knowledge of Risk and Protective Factors, Innlandet Hospital Trust (Norway), Inserm: Unit 1061, Institute of Health and Society: University of Oslo, Institute of Neurology: National Hospital for Neurology and Neurosurgery, Irish Journal of Psychological Medicine, Israel, Johns Hopkins University (Baltimore), Kaiser Permanente Washington Health Research Institute, Keck School of Medicine, La Colombière Hospital, Lancet, Lancet Commission on Dementia Prevention Intervention and Care, Lancet Commission on Dementia Prevention Intervention and Care (LCDPIC), Later Life, LCDPIC: Lancet Commission on Dementia Prevention Intervention and Care, Leonard Davis School of Gerontology: University of Southern California, Life-Course Approach to Healthy and Active Ageing, Life-Course Model of Dementia Prevention, Lifestyle Factors, Lifestyle Risk Factors, Lifestyle Weight Management, Loneliness, Loneliness and Social Isolation, Loneliness Harms Health, Marie Curie Palliative Care Research Department: University College London, Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, MCI: Mild Cognitive Impairment, Medical School: University of Exeter, Mediterranean Diet, Midlife Hypertension, Mild Cognitive Impairment (MCI), Minerva Center for Interdisciplinary Study of End of Life: Tel Aviv University, Modifiable Risk Factors, Mortality Risk Factors, National Ageing Research Institute (Australia) Academic Unit for Psychiatry of Old Age: University of Melbourne, Neurological Disorders, Neuroprotective Lifestyles, Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuropsychiatric Symptoms of Alzheimer’s Disease, Neuropsychiatry - Epidemiological and Clinical Research: La Colombière Hospital, Norway, Norwegian National Advisory Unit on Aging and Health (Norway), Obesity, Obesity Risk Factor, Overlapping Risk Factors, Physical Activity and Health Benefits, Physical Activity Before Dementia, Physical Exercise, Physical Exercise Programmes, Physical Inactivity, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Preclinical Dementia and Associated Lifestyle Changes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention Better Than Cure, Prevention of Dementia, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Prevention Programmes, Preventive Care, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Public Health, Public Health Interventions, Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Reducing the Incidence of Dementia, Research Networks, Resources for Enhancing Alzheimer’s Caregiver Health intervention (REACH), Risk and Protective Factors, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, Sackler Faculty of Medicine: Tel-Aviv University, School of Nursing: University of Washington, School of Public Health: Tel Aviv University, Sedentary Lifestyles, Sensory Impairments, Smoking Cessation, Social Activities, Social Epidemiology, Social Isolation, Socioeconomically Disadvantaged Populations (NIA Health Disparities Populations), Staying Healthy for Longer, STrAtegies for RelaTives (START), Successful Ageing, Supporting Healthy Lifestyles, Supporting People Affected by Dementia, T2DM, Tel Aviv University, Tobacco, Tobacco Cessation, Tobacco Consumption, Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes: Prevention, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, United States, University College London, University of Edinburgh, University of Exeter, University of Manchester, University of Melbourne, University of Michigan, University of Montpellier, University of Oslo, University of Southern California, University of Sussex, University of Washington, University of Washington (Seattle), USA, VA Center for Clinical Management Research (Ann Arbor USA), Vestfold Health Trust (Norway), Weight Management | Leave a comment

Roadmap for Dementia Research (International Journal of Geriatric Psychiatry / Alzheimer’s Society)

Posted on February 26, 2019 by Dementia and Elderly Care News

Summary Moving beyond the concentration upon research devoted to the discovery of pharmacological interventions for the treatment of dementia / Alzheimer’s Disease, the authors instead worked on a roadmap of complementary (non-pharmacological) research ambitions in the areas of prevention, diagnosis, … Continue reading →

Posted in Alzheimer's Society, Charitable Bodies, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, UK, Universal Interest, Wales | Tagged Ageing Population, Ageing Population Carer Support, Alzheimer's Research UK, Alzheimer's Society, Alzheimer’s Society Research Network, Bangor University, Barriers to Support, Brighton and Sussex Medical School: University of Sussex, Cambridge Institute of Public Health: University of Cambridge, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Research in Ageing and Cognitive Health: University of Exeter, Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia 2020 Challenge: 2018 Review Phase 1 (DHSC), Dementia Research, Dementia Research Priorities, Dementia Research Proposals, Dementia Services Development Centre: Bangor University, Division of Psychiatry: University College London, Enabling Dementia Workforce to Deliver Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Increasing Knowledge of Risk and Protective Factors, Institute for Ageing: Newcastle University, Institute for Health and Society: Newcastle University, International Journal of Geriatric Psychiatry, Katherine Cowan Consulting Ltd, Kings College London, London School of Economics and Political Science, LSE's Personal Social Services Research Unit (PSSRU), Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, National Dementia Strategies (UK), Newcastle University, Optimising Quality and Inclusivity of Health and Social Care Systems to Support People Affected by Dementia, Personal Social Service Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, PSSRU at LSE, PSSRU: London School of Economics and Political Science, Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Research Networks, Risk and Protective Factors, Roadmap to Advance Dementia Research by 2025 (Alzheimer’s Society), Roadmap to Advance Dementia Research by 2025: Care, Roadmap to Advance Dementia Research by 2025: Diagnosis, Roadmap to Advance Dementia Research by 2025: Interventions, Roadmap to Advance Dementia Research by 2025: Prevention, School of Clinical Medicine: University of Cambridge, Social Care Workforce Research Unit: King’s College London, Supporting People Affected by Dementia, University College London, University of Cambridge, University of Exeter, University of Exeter Medical School: University of Exeter, University of Sussex | Leave a comment

Brain Training in Later Life: Limited Value for Prevention of Cognitive Decline? (BBC News / BMJ / NHS Digital)

Posted on December 11, 2018 by Dementia and Elderly Care News

Summary A Scottish study indicates that self-reported intellectual engagement (in the form of performing puzzles, crosswords and other problem-solving activities) during later life has little influence on the trajectory of decline of memory or mental processing speed. The cognitive reserve … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Quick Insights, Scotland, UK, Universal Interest | Tagged Aberdeen Birth Cohort Studies, Alzheimer's Research UK, Bazian, BBC Health News, Behind the Headlines, Biology and Biotechnology Science Research Council, BMJ, BMJ Publishing Group Ltd, Brain Training, British Medical Journal (BMJ), Cognitive Decline, Cognitive Decline Studies, Cognitive Impairment, Cognitive Impairment (Potential Risk and Protective Factors), Cognitive Interventions, Cognitive Reserve, Cognitive Reserve Hypothesis, Cognitive Stimulation, Cognitive Training, Cognitive Training Exercises, Cognitively Stimulating Activities, Critical Appraisals, Curiosity (Openness), Dementia Risk Reduction and Prevention, Department of Psychology: National University of Ireland, Department of Psychology: University of Aberdeen, Engage Your Brain: GCBH Recommendations on Cognitively Stimulating Activities, Enjoyment and General Engagement, Global Council on Brain Health (GCBH), Healthy Ageing, Healthy Behaviours, Healthy Lifestyles, Healthy Living, Henry Smith Charity, Hobbies and Interests, Institute of Applied Health Sciences: University of Aberdeen, Intellectual Engagement (Self-Reported), Ireland, Lifelong Learning, Meaningful Activity, Meaningful Activity and Occupation, Meaningful Occupation, Medical Research Council, Mentally Challenging Occupations, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Modifiable Risk Factors, National University of Ireland (Galway), Neuroprotective Lifestyles, NHS Grampian (Aberdeen), Positive Engagement, Problem-Solving Skills, Progression of Mild Cognitive Impairment, Rates of Conversion From Mild Cognitive Impairment to Dementia, Scottish Government Health Department, Scottish Mental Health Survey of 1947, Skills and Hobbies, Slowing of Cognitive Decline, University of Aberdeen, Use It or Lose It Hypothesis, Use It or Lose It Hypothesis: Benefit of Cognitively Stimulating Activity, Wellcome Trust | Leave a comment

Grounds for Cautious Optimism Regarding Two Drugs Re-Purposed for Neurodegenerative Diseases? (BBC News / MRC / NHS Choices / Brain)

Posted on April 20, 2017 by Dementia and Elderly Care News

Summary Animal research, involving mice, has indicated promising results for the potential of two re-purposed drugs in helping to slow or halt the progression of a number of neurodegenerative brain diseases, including dementia. “The best known drug of the pair … Continue reading →

Posted in Animal Studies, BBC News, For Researchers (mostly), In the News, National, NHS Digital (Previously NHS Choices), Parkinson's Disease, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Abnormal Prion Protein, Alzheimer's Disease, Alzheimer's Research UK, Alzheimer’s Drug Discovery Foundation, Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK Drug Discovery Institute, Amyloid Beta, Amyloid Beta Protein, Amyloid Proteins, Amyloid-β (Aβ), Amyloid-β (Aβ) Accumulation, Autoimmune Attacks, Autoimmune Cell Defences, BBC Health News, Behind the Headlines, Brain (Journal), Centre for Analytical Bioscience: University of Nottingham, CJD, Creutzfeldt-Jakob Disease, Creuzfeldt Jacob Disease (CJD), Department of Clinical Neurosciences: University of Cambridge, Dibenzoylmethane, Dibenzoylmethane (DBM): Potential Anti-Cancer Drug, Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr David Dexter: Parkinson's UK, Dr Doug Brown: Director of Research and Development at Alzheimer's Society, Drug Discovery Programmes, eIF2a-P-Mediated Translational Repression (Pathway of Neurodegeneration), Frontotemporal Dementia (FTD), Huntingtin Protein, Huntington’s Disease, α-Synuclein, α-Synuclein Aggregation, Lentivirally Mediated RNA Interference (RNAi), Medical Research Council (MRC), Medical Research Council (UK), Medical Research Council Toxicology Unit: University of Leicester, Medical Research Council’s (MRC) Toxicology Unit, Microscopic Worms, Misfolded Prion Protein (PrP), Misfolded Proteins, Motor Neurone Disease (MND), MRC Toxicology Unit: University of Leicester, MRC: Medical Research Council, Multiple Sclerosis, National Institute for Neurological Disorders and Stroke, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neuronal Loss, Neuroprotection, Parkinson's, Potential Repurposing of Drugs to Slow Progression of Alzheimer’s Disease, Prion Diseases, Prion Protein (PrP(C)), Prion-Infected Mice, Prof. Giovanna Mallucci, Professor Giovanna Mallucci: Associate Drector of UK Dementia Research Institute, Protein Misfolding, Rare Prion Diseases, Repurposing of Drugs, Synucleinopathy, Tau, Tau Protein, Tauopathy, Translational Research, Transmissible Spongiform Encephalopathies, Trazodone, Trazodone Hydrochloride (Antidepressant), UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), Unfolded Protein Response (UPR), University of Cambridge, University of Leicester, University of Nottingham, Worms: C. elegans | Leave a comment

David Cameron on Need for Increasing Dementia Research Funding (BBC News)

Posted on January 26, 2017 by Dementia and Elderly Care News

Summary David Cameron, the former Prime Minister, has taken-up the role of President of Alzheimer’s Research UK (in addition to working for the National Citizen Service). He has proposed / re-stated the importance of greater levels of funding for dementia … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, Commissioning, In the News, Management of Condition, Mental Health, National, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK, Universal Interest | Tagged Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, BBC Health News, BBC Politics News, Challenge on Dementia (David Cameron), Challenge on Dementia 2020, David Cameron, David Cameron: Former Prime Minister, David Cameron: President of Alzheimer's Research UK, Defeat Dementia Campaign, Defeat Dementia Campaign (Alzheimer’s Research UK), Dementia Awareness, Dementia Awareness Raising, Dementia Research, Dementia Research Funding, Dementia Risk Prevention, Dementia Risk Reduction and Prevention, Dementia-Friendly Communities, Dementia-Friendly Environments, Investment in Dementia Prevention, National Citizen Service, National Citizen Service in England and Northern Ireland, Prevention Agenda, Prime Minister's Challenge on Dementia, Prime Minister’s Challenge On Dementia 2020, The Rt Hon David Cameron: President of Alzheimer’s Research UK | Leave a comment

Repurposing of Existing Drugs to Prevent Dementia? (BBC News / Science Advances /Alzheimer’s Research UK)

Posted on February 13, 2016 by Dementia and Elderly Care News

Summary A number of drugs, already approved as safe for the treatment of other conditions, and which could help protect against Alzheimer’s Disease, are said to have been detected and short-listed for further investigation. Full Text Link Reference Alzheimer’s preventative … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Animal Studies, BBC News, Charitable Bodies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Ab42 Fibril Formation, Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK Drug Discovery Institute, Amyloid Beta Protein, Amyloid Cascade Hypothesis, Amyloid Hypothesis, Amyloid Proteins, Amyloid-β (Aβ), Amyloid-β Protein, Anti-Amyloid Therapies, ARUK: Alzheimer’s Research UK, ß-amyloid, BBC Health News, Behind the Headlines, Beta-Amyloid, Bexarotene (Elevated Triglycerides), Bexarotene (Targretin), Center for Molecular Protein Science: Lund University, Cleveland Clinic Lou Ruvo Center for Brain Health, Collaborative Drug Discovery Programmes, Conversion to Dementia From Prodromal Disease, Critical Appraisals, Department of Biochemistry and Structural Biology: Lund University, Department of Chemistry: University of Cambridge, Department of Psychology: University of Nevada, Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Drug Discovery Programmes, European Research Institute for the Biology of Aging (Groningen), Fibrillar Deposits (Alzheimer's Disease), Fibrils, β-Amyloid 1-42 (Aβ42), Lund University (Sweden), Microscopic Worms, Netherlands, Neurofibrillary Tangles (NFTs), Neurological Research, Neurostatin (Hypothetical Construct), Off-Label Drug Repurposing Trials, Off-Licence Drugs, Potential Repurposing of Drugs to Slow Progression of Alzheimer’s Disease, Prodromal Alzheimer's Disease, Protein Aggregation, Repurposing of Drugs, RXR Agonists, Science Advances (Journal), Statins for the Brain (Hypothetical Construct), Sweden, University Medical Centre Groningen, University of Cambridge, University of Groningen, University of Nevada, USA, Worms: C. elegans | Leave a comment

Exploration of Dementia Carers’ Lived Experience (BBC News / ARUK)

Posted on December 19, 2015 by Dementia and Elderly Care News

Summary Alzheimer’s Research UK commissioned Opinion Leader to investigate all aspects of the impact of caring for a relative with dementia. “Opinion Leader worked with families to produce a rich description of individual experiences, by conducting a series of four … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, Community Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Statistics, UK | Tagged Ageing and Dementia, Ageing and Society, Ageing Population, Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, Awareness, Awareness and Understanding, Balancing Work With Caring, BBC Health News, Behavioural and Psychological Symptoms of Dementia (BPSD), Behavioural Symptoms, BPSD: Behavioral and Psychological Symptoms of Dementia, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Burden on Caregivers, Caregiver Assessments, Caregiver Burden, Caregiver Distress, Caregiver Support, Caregivers, Caregiving (Carers), Carer Awareness, Carer Experience, Carer Fatigue, Carer Isolation, Carer Satisfaction, Carer Support, Carer Support Services, Carer's Experience of Dementia, Carer's Needs, Carer’s Needs Assessment, Carer’s Perspective, Carers, Carers and Families, Carers Direct, Carers for People with Dementia, Carers’ Health and Wellbeing, Caring for Carers, Caring: Hidden Costs, Caring: Impact on Personal Goals, Caring: Psychological Health of Carers, Changing Behaviours, Dementia Awareness, Dementia in the Family (ARUK Report), Differential Impact of Dementia (Gender-Related), Disease Burden, Disproportionate Burden of Dementia on Women, Disproportionate Impact of Dementia on Women, Ethnographic Analysis, Ethnographic Approaches, Ethnographic Research, Experiences, Family and Caregiver Experiences, Family Caregivers, Family Carers, Health and Wellbeing of Adult Carers, Impact of Caring on Ability to Work, Impact of Caring on Carers, Informal Caregiving, Informal Carers, Informal Workforce, Information and Support for Carers, Lived Experience, Mental and Physical Health, Opinion Leader, Personal Experience of Dementia, Positive Care Experiences, Prevalence of Dementia, Prevalence of Unpaid Care, Raising the Profile of Carers, Social Isolation, Support for Carers, Unexpected Positives in Caring, Unpaid Caregivers (Carers), Unpaid Carers, Valuing Carers, Views of Informal Carers, Working and Caring, Working Carers | Leave a comment

Dementia Discovery Fund Launched (WDC / ARUK)

Posted on November 18, 2015 by Dementia and Elderly Care News

Summary The Dementia Discovery Fund (DDF) was launched on October 21st 2015. Full Text Link Reference Launch of Dementia Discovery Fund. London [Online]: World Dementia Council (WDC), November 10th 2015. See also: Full Text Link Reference $100m Dementia Discovery Fund … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged $100m Dementia Discovery Fund, Ageing and Dementia, Ageing and Society, Ageing Population, Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), Andrew Plump: Chief Medical and Scientific Officer at Takeda Pharmaceutical Company Limited, ARUK: Alzheimer’s Research UK, Big Pharma, Biogen, Biopharmaceutical Companies, Collaboration, Collaborative Projects, Cross-Sector Partnerships, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Research, Dementia Research Funding, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Jan Lundberg: President of Lilly Research Laboratories, Dr Matthew Norton: Alzheimer's Research UK, Drug Discovery Programmes, Drug Identification, Drug Regulation, Drug-Development Pipeline, Eli Lilly Inc., Eli Lilly’s UK Dementia Research Centre, First Global Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia, G8 Dementia Summit: Global Action Against Dementia, GlaxoSmithKline, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Ministerial Conference on Global Action Against Dementia (WHO), Global Outlook, Government Research Funding, GSK Johnson & Johnson, International Collaborations, International Programmes, Jane Ellison, Johnson & Johnson, Lilly, Mikael Dolsten: President of Worldwide Research and Development at Pfizer, Partnership, Partnership and Collaboration, Partnership Working, Patrick Vallance: President of Pharmaceuticals R&D at GSK, Paul Stoffels: Worldwide Chairman of Johnson & Johnson, Pfizer, Pfizer Inc., Pharmaceutical Industry, Research and Development, Research and Innovation, Research Commitment, Research Funding, SV Life Sciences, SV Life Sciences (SVLS), Takeda, WDC: World Dementia Council, World Dementia Council | Leave a comment

Altered Humour Predicts Behavioural Variant Frontotemporal Dementia? (BBC News / MRC / JAD / Cortex)

Posted on November 12, 2015 by Dementia and Elderly Care News

Summary Researchers at University College London are interested in whether sense of humour changes might help predict frontotemporal dementia (FTD). Their latest paper suggests that changes in sense of humour can be an early sign of this type of dementia, … Continue reading →

Posted in BBC News, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Quick Insights, UK, Universal Interest | Tagged Altered Humour, Altered Sense of Humour, Alzheimer's Research UK, BBC Health News, Behavioural Frontotemporal Dementia (bvFTD), Behavioural Variant Frontotemporal Dementia (bvFTD), BV-FTD, Canadian Institutes of Health Research, Changes in Humour, Cortex (Journal), Dementia Research Centre: University College London, Dementia Research Centre: University College London: UCL Institute of Neurology: University College London, Frankly Inappropriate Humour Responses, Fronto-Temporal Dementia (FTD), Frontotemporal Dementia (FTD), Frontotemporal Lobar Degeneration, Frontotemporal Lobar Degeneration (FTLD), FTLD: Frontotemporal Lobar Degeneration, Humour in Dementia, Humour Processing in Frontotemporal Lobar Degeneration, JAD, Journal of Alzheimer's Disease, Medical Research Council (MRC), MRC, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neurology, NIHR Queen Square Dementia Biomedical Research Unit, Semantic Dementia, UCL Institute of Neurology: University College London, University College London, Wellcome Trust | Leave a comment

Announcements From WHO’s First Ministerial Conference on Global Action Against Dementia Conference (Dementia Challenge / Department of Health / World Dementia Council / WHO / GAAD)

Posted on March 18, 2015 by Dementia and Elderly Care News

Summary Health Secretary Jeremy Hunt has announced a $100 million Dementia Discovery Fund at the World Health Organisation’s First Ministerial Conference on Global Action Against Dementia Conference. The Dementia Discovery Fund will be used to finance dementia research with the … Continue reading →

Posted in Acute Hospitals, Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NIHR, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest, World Health Organization (WHO) | Tagged $100m Dementia Discovery Fund, Ageing and Dementia, Ageing and Society, Ageing Population, Alzheimer's Research UK, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, Awareness Raising, Big Pharma, Biogen, Biopharmaceutical Companies, Burden of Dementia, Challenge on Dementia (David Cameron), Collaboration, Collaborative Projects, Cross-Sector Partnerships, Dementia Challenge, Dementia Diagnosis, Dementia Discovery Fund, Dementia Research, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Margaret Chan: WHO Director-General, Drug Discovery Programmes, Drug Identification, Drug Regulation, Drug-Development Pipeline, Eli Lilly Inc., Eli Lilly’s UK Dementia Research Centre, First Global Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia, Former Health Secretary Jeremy Hunt, G8 Dementia Summit: Global Action Against Dementia, GlaxoSmithKline, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Ministerial Conference on Global Action Against Dementia (WHO), Global Outlook, Government Research Funding, Human Rights, International Collaborations, International Programmes, Johnson & Johnson, JP Morgan, Knowledge Translation, Leadership, Lilly, Ms. Cathrin Petty: JP Morgan, OECD, Organisation for Economic Co-operation and Development (OECD), Organisation for Economic Co-operation and Development (OECD) Countries, Partnership, Partnership and Collaboration, Partnership Working, Pfizer, Pfizer Inc., Pharmaceutical Industry, Prime Minister’s Dementia Challenge, Quality of Care, Quality of Care and Support, Quality of Care for People With Dementia, Reducing Stigma, Research and Development, Research and Innovation, Research Commitment, Research Funding, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO) | Leave a comment

Tag Archives: Alzheimer’s Research UK

Brain Training in Later Life: Limited Value for Prevention of Cognitive Decline? (BBC News / BMJ / NHS Digital)

Grounds for Cautious Optimism Regarding Two Drugs Re-Purposed for Neurodegenerative Diseases? (BBC News / MRC / NHS Choices / Brain)

David Cameron on Need for Increasing Dementia Research Funding (BBC News)

Repurposing of Existing Drugs to Prevent Dementia? (BBC News / Science Advances /Alzheimer’s Research UK)

Dementia Discovery Fund Launched (WDC / ARUK)

Altered Humour Predicts Behavioural Variant Frontotemporal Dementia? (BBC News / MRC / JAD / Cortex)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites